Addressing Inequity in Dermatology

NCT ID: NCT06056648

Last Updated: 2023-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-21

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study are to understand the variation in dermatoses presenting in individuals from different ancestry backgrounds. This will be conducted at multiple NHS hospitals in England. The Investigators specifically aim to 1) assess features of dermatoses in individuals of different ancestry. 2) Understand the language used by patients describing their condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dermatologic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Dermatologist diagnosed disease, with visible active dermatological disease

Exclusion Criteria

* No dermatological disease, no active pathology identifiable, aged 18 and above but lacks capacity to consent.
Minimum Eligible Age

7 Days

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dowager Countess Eleanor Peel Trust

UNKNOWN

Sponsor Role collaborator

University of Manchester

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Elise Kleyn

Chief Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chiedu Ufodiama, MBBS M.Sci

Role: PRINCIPAL_INVESTIGATOR

University of Manchester

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Salford Royal NHS Foundation Trust

Salford, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chiedu Ufodiama

Role: CONTACT

0161 306 6000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chiedu Ufodiama, MBChB

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NHS001958

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Epidermal Growth Factor Receptor Inhibition for Keratinopathies
NCT06545695 NOT_YET_RECRUITING PHASE1/PHASE2
Artificial Intelligence Patient App for RDEB SCCs
NCT05843994 ACTIVE_NOT_RECRUITING